Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines - Scientific guideline

Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines.

Keywords: /

Current effective version

Public statement on the evaluation of bovine spongiform encephalopathies (BSE) - risk via the use of materials of bovine origin in or during the manufacture of vaccines

AdoptedLegal effective date: 28/02/2001Reference Number: EMEA/CPMP/BWP/476/01